Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

MetricBNTXBiontech SEINCYIncyteMRNAModerna
Snapshot
Price$95.30$116.86$79.76
Market cap$24.67B$23.35B$31.65B
Valuation
P/E—16.3x—
Forward P/E—11.7x—
Growth
Revenue growth-11.8%21.5%-30.0%
EPS growth—2455.3%—
Profitability
Net margin-34.0%26.7%-143.6%
ROE-6.7%29.2%-36.7%
Balance sheet & cash
Debt / equity0.01x0.01x0.07x
Free cash flow yield13.6%2.2%-13.6%
Dividend yield———
Verdict
Investment ratingWeak· 31Strong· 86Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBNTXtoday $95INCYtoday $117MRNAtoday $80
2027$72.90 – $106.93+12% CAGR$2,239.60 – $3,284.75+2711% CAGR$61.02 – $89.49+12% CAGR
2028$74.36 – $109.07+7% CAGR$57,228.76 – $83,935.51+2580% CAGR$62.24 – $91.28+7% CAGR
2029$75.85 – $111.25+5% CAGR$1,462,372.22 – $2,144,812.59+2538% CAGR$63.48 – $93.11+5% CAGR
2030$77.37 – $113.47+4% CAGR$37,368,143.63 – $54,806,610.65+2517% CAGR$64.75 – $94.97+4% CAGR
2031$78.91 – $115.74+4% CAGR$954,871,910.91 – $1,400,478,802.66+2504% CAGR$66.05 – $96.87+4% CAGR
5-yr CAGR-3.7% – 4.0%2312.4% – 2504.5%-3.7% – 4.0%